Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 257,884 |
|
|||||
| News | (1) | ||||||
| Day High | 0.89 | Low High |
|||||
| Day Low | 0.86 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Femasys Inc | FEMY | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0119 | -1.35% | 0.8701 | 18:58:31 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.88 | 0.86 | 0.89 | 0.889 | 0.882 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 645 | 257,884 | US$ 0.8776941 | US$ 226,343 | - | 0.2479 - 4.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:31:01 | formt | 500 | US$ 0.8701 | USD |
Femasys Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 19.05M | 21.65M | - | 1.21M | -11.39M | -0.53 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Femasys News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/08/2023 | 08:28 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/30/2023 | 16:17 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 11/29/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/22/2023 | 15:39 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/22/2023 | 15:33 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 11/22/2023 | 15:12 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 11/21/2023 | 16:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/15/2023 | 16:19 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/15/2023 | 07:30 | Business Wire | PharmaCyte Biotech Acquires $5 Million Stake in Emerging.. |
| 11/01/2023 | 20:40 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/11/2023 | 07:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/03/2023 | 08:28 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FEMY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.90 | 0.950161 | 0.86 | 0.9083605 | 378,499 | -0.0299 | -3.32% |
| 1 Month | 1.25 | 1.25 | 0.8401 | 0.9812851 | 1,289,424 | -0.3799 | -30.39% |
| 3 Months | 0.3575 | 4.75 | 0.2479 | 2.21 | 11,102,916 | 0.5126 | 143.38% |
| 6 Months | 0.8126 | 4.75 | 0.2479 | 1.83 | 7,059,833 | 0.0575 | 7.08% |
| 1 Year | 1.10 | 4.75 | 0.2479 | 1.83 | 3,572,916 | -0.2299 | -20.9% |
| 3 Years | 13.08 | 13.75 | 0.2479 | 1.96 | 1,530,154 | -12.21 | -93.35% |
| 5 Years | 13.08 | 13.75 | 0.2479 | 1.96 | 1,530,154 | -12.21 | -93.35% |
Femasys Description
| Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. |
